GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of ARS 139.28 trillion. The enterprise value is 166.29 trillion.

Market Cap	139.28T
Enterprise Value	166.29T

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Nov 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	86.65%
Float	3.89B

Valuation Ratios

The trailing PE ratio is 13.76 and the forward PE ratio is 10.04.

PE Ratio	13.76
Forward PE	10.04
PS Ratio	2.35
PB Ratio	4.80
P/TBV Ratio	n/a
P/FCF Ratio	11.68
P/OCF Ratio	9.70
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 13.95.

EV / Earnings	16.43
EV / Sales	2.69
EV / EBITDA	8.89
EV / EBIT	12.70
EV / FCF	13.95

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.13.

Current Ratio	0.84
Quick Ratio	0.54
Debt / Equity	1.13
Debt / EBITDA	1.82
Debt / FCF	2.74
Interest Coverage	10.96

Financial Efficiency

Return on equity (ROE) is 41.52% and return on invested capital (ROIC) is 13.51%.

Return on Equity (ROE)	41.52%
Return on Assets (ROA)	7.13%
Return on Invested Capital (ROIC)	13.51%
Return on Capital Employed (ROCE)	17.02%
Revenue Per Employee	863.44M
Profits Per Employee	147.48M
Employee Count	68,629
Asset Turnover	0.54
Inventory Turnover	1.47

Taxes

In the past 12 months, GSK plc has paid 1.75 trillion in taxes.

Income Tax	1.75T
Effective Tax Rate	13.56%

Stock Price Statistics

The stock price has increased by +92.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+92.57%
50-Day Moving Average	17,176.20
200-Day Moving Average	13,459.43
Relative Strength Index (RSI)	56.51
Average Volume (20 Days)	280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of ARS 59.26 trillion and earned 10.12 trillion in profits. Earnings per share was 2,447.74.

Revenue	59.26T
Gross Profit	42.92T
Operating Income	12.54T
Pretax Income	12.92T
Net Income	10.12T
EBITDA	17.54T
EBIT	12.54T
Earnings Per Share (EPS)	2,447.74

Full Income Statement

Balance Sheet

The company has 6.09 trillion in cash and 32.70 trillion in debt, giving a net cash position of -26,609.00 billion.

Cash & Cash Equivalents	6.09T
Total Debt	32.70T
Net Cash	-26,609.00B
Net Cash Per Share	n/a
Equity (Book Value)	29.02T
Book Value Per Share	7,389.01
Working Capital	-6,433.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.35 trillion and capital expenditures -2,429.89 billion, giving a free cash flow of 11.92 trillion.

Operating Cash Flow	14.35T
Capital Expenditures	-2,429.89B
Free Cash Flow	11.92T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.43%, with operating and profit margins of 21.17% and 17.08%.

Gross Margin	72.43%
Operating Margin	21.17%
Pretax Margin	21.81%
Profit Margin	17.08%
EBITDA Margin	29.59%
EBIT Margin	21.17%
FCF Margin	20.12%

Dividends & Yields

This stock pays an annual dividend of 476.22, which amounts to a dividend yield of 2.59%.

Dividend Per Share	476.22
Dividend Yield	2.59%
Dividend Growth (YoY)	50.85%
Years of Dividend Growth	3
Payout Ratio	46.05%
Buyback Yield	-0.08%
Shareholder Yield	2.51%
Earnings Yield	7.27%
FCF Yield	8.56%

Dividend Details

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.81
Piotroski F-Score	7